BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 17647198)

  • 1. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.
    Chong ZZ; Maiese K
    Histol Histopathol; 2007 Nov; 22(11):1251-67. PubMed ID: 17647198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shp-2 tyrosine phosphatase: signaling one cell or many.
    Feng GS
    Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.
    Arnaud M; Mzali R; Gesbert F; Crouin C; Guenzi C; Vermot-Desroches C; Wijdenes J; Courtois G; Bernard O; Bertoglio J
    Biochem J; 2004 Sep; 382(Pt 2):545-56. PubMed ID: 15170389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
    Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM
    J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response.
    Qu CK
    Biochim Biophys Acta; 2002 Nov; 1592(3):297-301. PubMed ID: 12421673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
    Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
    J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
    Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
    J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
    Poole AW; Jones ML
    Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling.
    Wang N; Li Z; Ding R; Frank GD; Senbonmatsu T; Landon EJ; Inagami T; Zhao ZJ
    J Biol Chem; 2006 Aug; 281(31):21878-21883. PubMed ID: 16762922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
    Qu CK; Feng GS
    Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune signalling: SHP-2 docks at multiple ports.
    Huyer G; Alexander DR
    Curr Biol; 1999 Feb; 9(4):R129-32. PubMed ID: 10074424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling.
    Zhao R; Zhao ZJ
    Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):35-9. PubMed ID: 9931295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR; Welham MJ
    Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.
    Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T
    EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.